2024 Buick Envista Sport Touring
1.2 L • I3 • 137 hp • FWD • AT
KL47LBE25RB025757
Sales history: 1
• $2,900Highlights
Condition
Not provided
Seller
Unknown
Key included
Yes
Docs
Good
History
1 record
Drive
1.2 L • I3 • 137 hp • FWD • AT
Odometer
Not provided
Primary damage
Front end
Secondary damage
Undercarriage
Docs
NC • Salvage Title
Extra
Auction
VIN
KL47LBE25RB025757
Lot number
82754665
Copart
Sale status
Sold
Location
Mocksville, NC
Description
Fuel type
Gasoline
Body color
White
Body type
SUV
Trim
Sport Touring
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2024 Buick Envista Sport Touring • 1.2 L • I3 • 137 hp • FWD • Automatic • Copart Lot: 82754665 • VIN: KL47LBE25RB025757
Find out more about this 2024 Buick Envista Sport Touring, available at the Copart salvage car auction as lot 82754665 in Mocksville, NC. This car has Front end main damage. It is listed with Not provided start condition code. Odometer shows Not provided. This White Buick Envista SUV is equipped with Gasoline 1.2 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KL47LBE25RB025757 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
